Monash IVF GroupMNIVF 78 Receivables Turnover is 8.37 as of Dec. 2025. GuruFocus rates MNIVF with a GF Score™ of 78/100 and a GF Value™ of $0.79. The stock has 7 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, Monash IVF Group ranks better than 89.16% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Monash IVF Group's Revenue for the
six
months ended in Dec. 2025 was $91.6 Mil. Monash IVF Group's average Accounts Receivable for the
six
months ended in Dec. 2025 was $10.9 Mil.
Hence, Monash IVF Group's Receivables Turnover for the
six
months ended in Dec. 2025 was 8.37.
Monash IVF Group (OTCPK:MNIVF) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Monash IVF Group Receivables Turnover Related Terms
Monash IVF Group Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Monash IVF Group's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MNIVF vs TMO, DHR, IDXX: Receivables Turnover Comparison
For the Diagnostics & Research subindustry, Monash IVF Group's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monash IVF Group Receivables Turnover vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Monash IVF Group's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Monash IVF Group's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monash IVF Group (MNIVF) has a Receivables Turnover of 8.37 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Monash IVF Group and its competitors. According to the industry distribution chart, Monash IVF Group ranks #22 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 10.8%.
Is Monash IVF Group's Receivables Turnover too high?
Monash IVF Group's current Receivables Turnover is 8.37. The Medical Diagnostics & Research industry median Receivables Turnover is 5.39. Monash IVF Group's value of 8.37 is 55.3% above this industry median. Based on the distribution chart, Monash IVF Group ranks #22 out of 203 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Monash IVF Group has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Monash IVF Group's Receivables Turnover compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Monash IVF Group ranks #22 out of 203 companies for Receivables Turnover. This places Monash IVF Group in the top 11% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.39. Monash IVF Group's value of 8.37 is 55.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Diagnostics & Research company?
The median Receivables Turnover among Medical Diagnostics & Research companies is 5.39, based on 203 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Monash IVF Group's current Receivables Turnover of 8.37 is 55.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Monash IVF Group and its competitors. For the Medical Diagnostics & Research industry, the median Receivables Turnover is 5.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Monash IVF Group's current Receivables Turnover is 8.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monash IVF Group stock overvalued right now?
Monash IVF Group (MNIVF) has a current Receivables Turnover of 8.37. The stock's GF Value™ is $0.79, compared to a current price of $0.40 — trading 49.4% below its estimated fair value. The current Receivables Turnover is 8.37 and 55.3% above the Medical Diagnostics & Research industry median of 5.39. Monash IVF Group's overall GF Score™ is 78/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Monash IVF Group (MNIVF), the current Receivables Turnover is 8.37 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Monash IVF Group (MNIVF) Overvalued in 2026?
Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued.
The current stock price of $0.40 is trading 49.4% below its estimated GF Value™ of $0.79.
Key valuation signals for MNIVF:
Receivables Turnover: 8.37
GF Value™: $0.79 vs. price of $0.40 (49.4% below fair value)
Industry Position: 55.3% above the Medical Diagnostics & Research median (#22 of 203)
No single metric tells the full story. See the MNIVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
78GF Score
Get the complete analysis for MNIVF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNIVF has been successfully added to your 
